M&A Deal Summary

Ferrer Pharma Acquires Alexza Pharmaceuticals

On May 10, 2016, Ferrer Pharma acquired life science company Alexza Pharmaceuticals for 35M USD

Acquisition Highlights
  • This is Ferrer Pharma’s 1st transaction in the Life Science sector.
  • This is Ferrer Pharma’s largest (disclosed) transaction.
  • This is Ferrer Pharma’s 1st transaction in the United States.
  • This is Ferrer Pharma’s 1st transaction in California.

M&A Deal Summary
Date 2016-05-10
Target Alexza Pharmaceuticals
Sector Life Science
Buyer(s) Ferrer Pharma
Deal Type Add-on Acquisition
Deal Value 35M USD
Advisor(s) Guggenheim Securities (Financial)
Cooley (Legal)

Target

Alexza Pharmaceuticals

Mountain View, California, United States
Alexza Pharmaceuticals, Inc. is a developer of drugs for acute and intermittent medical conditions. Their Staccato system aerosolizes without thermal degradation, enabling convenient delivery and rapid therapeutic onset of many small molecule drugs.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ferrer Pharma

United States
Category Company
Sector Life Science
DESCRIPTION

Ferrer Pharma, Inc. is a pharmaceutical company.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal